Related Experiment Video

Updated: Sep 21, 2025

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.6K

The interaction between ETS transcription factor family members and microRNAs: A novel approach to cancer therapy

Liwei Du1, Yuchen Liu2, Chenxi Li1

  • 1Jiangxi Key Laboratory of Cancer Metastasis and Precision Treatment, Department of Center Laboratory, The Third Affiliated Hospital of Nanchang University & The First Hospital of Nanchang, Nanchang 330008, China.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|June 5, 2022
PubMed

Insights

ETS transcription factors and microRNAs (miRNAs) interact to influence cancer development. Understanding these interactions, including competing endogenous RNAs (ceRNAs), offers new therapeutic strategies for tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • ETS transcription factors are key regulators in cancer, promoting tumorigenesis through gene regulation.
  • MicroRNAs (miRNAs) are posttranscriptional regulators involved in tumor suppression and promotion.
  • The interplay between ETS factors and miRNAs shapes complex cancer networks.

Purpose of the Study:

  • To review the intricate roles of ETS factors and miRNAs in cancer biology.
  • To detail the interactions within the miRNA/ETS axis, competing endogenous RNAs (ceRNAs), posttranslational modifications (PTMs), and the tumor microenvironment (TME).
  • To explore the therapeutic potential of targeting ETS factors and miRNAs in cancer treatment.

Main Methods:

  • Literature review focusing on ETS factors, miRNAs, ceRNAs, PTMs, and the TME in cancer.
  • Analysis of regulatory networks and interactions between these molecular players.
  • Exploration of current and prospective therapeutic strategies.

Main Results:

  • ETS factors and miRNAs form complex regulatory networks crucial for tumorigenesis.
  • The miRNA/ETS axis interacts with ceRNAs, influencing PTMs and the TME.
  • These interactions provide novel insights into cancer development and progression.

Conclusions:

  • The interplay between ETS factors and miRNAs offers a deeper understanding of cancer biology.
  • Targeting the miRNA/ETS axis and related pathways presents promising therapeutic avenues for malignant tumors.
  • Further research into these interactions can lead to innovative cancer treatment strategies.
Keywords:
Cancer therapyCeRNAETSMiRNAThe tumor microenvironmentTranscription factor

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.5K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.9K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K